Bioharvest Sciences Inc (BHST)

$5.83 -0.07 (-1.21%)
Market Cap 96.91M
Revenue (ttm) 12.67M
Net Income (ttm) -12.56M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -99.13%
Debt to Equity Ratio 0.29
Volume 2,500
Avg Vol 9,810
Day's Range N/A - N/A
Shares Out 16.43M
Stochastic %K 0%
Beta N/A
Analysts Strong Sell
Price Target $13.00

Latest News on BHST

BioHarvest Issues Shareholder Letter and Provides Corporate Update

Jan 8, 2025, 8:41 AM EST - 10 days ago

BioHarvest Issues Shareholder Letter and Provides Corporate Update

Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology

Dec 11, 2024, 6:00 AM EST - 5 weeks ago

Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology

BioHarvest Sciences Inc. (BHST) Q3 2024 Earnings Call Transcript

Nov 25, 2024, 7:01 PM EST - 7 weeks ago

BioHarvest Sciences Inc. (BHST) Q3 2024 Earnings Call Transcript

BioHarvest Sciences Reports Third Quarter 2024 Financial Results

Nov 25, 2024, 4:05 PM EST - 7 weeks ago

BioHarvest Sciences Reports Third Quarter 2024 Financial Results

BioHarvest Launches VINIA SuperFood Functional Tea Line

Nov 25, 2024, 8:30 AM EST - 7 weeks ago

BioHarvest Launches VINIA SuperFood Functional Tea Line

BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024

Nov 21, 2024, 8:30 AM EST - 2 months ago

BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024

BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 P.M. Eastern Time

Nov 18, 2024, 8:30 AM EST - 2 months ago

BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 P.M. Eastern Time

BioHarvest Sciences Begins Trading on the Nasdaq Global Market

Nov 12, 2024, 8:30 AM EST - 2 months ago

BioHarvest Sciences Begins Trading on the Nasdaq Global Market

BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market

Nov 7, 2024, 8:30 AM EST - 2 months ago

BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market

BioHarvest Sciences Announces Record Preliminary Third Quarter 2024 Financial Results

Oct 23, 2024, 8:30 AM EDT - 3 months ago

BioHarvest Sciences Announces Record Preliminary Third Quarter 2024 Financial Results

BioHarvest Sciences to Participate in LD Micro Main Event XVII Conference on October 30, 2024

Oct 16, 2024, 8:47 AM EDT - 3 months ago

BioHarvest Sciences to Participate in LD Micro Main Event XVII Conference on October 30, 2024

BioHarvest Sciences Reports Director's Ongoing Key Role Following Resignation from Board

Sep 20, 2024, 8:30 AM EDT - 4 months ago

BioHarvest Sciences Reports Director's Ongoing Key Role Following Resignation from Board

BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on September 24-25, 2024

Sep 12, 2024, 8:30 AM EDT - 4 months ago

BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on September 24-25, 2024

BioHarvest Sciences to Present at H.C. Wainwright 26th Annual Global Investment Conference

Sep 4, 2024, 8:30 AM EDT - 4 months ago

BioHarvest Sciences to Present at H.C. Wainwright 26th Annual Global Investment Conference

BioHarvest Sciences Reports Record Second Quarter 2024 Financial Results

Aug 29, 2024, 9:22 AM EDT - 5 months ago

BioHarvest Sciences Reports Record Second Quarter 2024 Financial Results

BioHarvest Sciences Surpasses USD $1.0 Million in Cumulative Direct Sales of Coffee with VINIA Inside

Aug 28, 2024, 9:56 AM EDT - 5 months ago

BioHarvest Sciences Surpasses USD $1.0 Million in Cumulative Direct Sales of Coffee with VINIA Inside

BioHarvest Sciences to Host Second Quarter 2024 Corporate Update Call on August 29, 2024, at 2:30 p.m. Eastern Time

Aug 23, 2024, 8:30 AM EDT - 5 months ago

BioHarvest Sciences to Host Second Quarter 2024 Corporate Update Call on August 29, 2024, at 2:30 p.m. Eastern Time

BioHarvest Sciences Announces Closing of USD $4,329,982 in First Tranche of Private Placement and Conversion of Debt Notes

Jun 28, 2024, 2:52 PM EDT - 7 months ago

BioHarvest Sciences Announces Closing of USD $4,329,982 in First Tranche of Private Placement and Conversion of Debt Notes

BioHarvest Sciences to Present at Noble Capital Markets Virtual Equity Conference on June 27, 2024

Jun 24, 2024, 8:30 AM EDT - 7 months ago

BioHarvest Sciences to Present at Noble Capital Markets Virtual Equity Conference on June 27, 2024

BioHarvest Sciences Announces a Private Placement of up to USD $5 Million and Conversion of Debt Notes

Jun 21, 2024, 8:30 AM EDT - 7 months ago

BioHarvest Sciences Announces a Private Placement of up to USD $5 Million and Conversion of Debt Notes

BioHarvest Sciences to Present at Sidoti Small-Cap Virtual Investor Conference on June 13, 2024

Jun 12, 2024, 4:16 PM EDT - 7 months ago

BioHarvest Sciences to Present at Sidoti Small-Cap Virtual Investor Conference on June 13, 2024

BioHarvest Sciences Announces Record $2 Million Monthly Sales

Jun 6, 2024, 8:30 AM EDT - 8 months ago

BioHarvest Sciences Announces Record $2 Million Monthly Sales

BioHarvest Sciences Reports First Quarter 2024 Financial Results

May 30, 2024, 8:30 AM EDT - 8 months ago

BioHarvest Sciences Reports First Quarter 2024 Financial Results

BioHarvest Sciences to Host Corporate Update Call May 2 at 2:30 P.M. Eastern Time

May 1, 2024, 9:15 AM EDT - 9 months ago

BioHarvest Sciences to Host Corporate Update Call May 2 at 2:30 P.M. Eastern Time

BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results

Apr 30, 2024, 8:00 AM EDT - 9 months ago

BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results

BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity

Apr 16, 2024, 8:00 AM EDT - 9 months ago

BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity

BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables

Mar 21, 2024, 8:30 AM EDT - 10 months ago

BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables

BioHarvest Sciences to Participate in Benzinga Virtual Healthcare Summit 2024 on March 20, 2024

Mar 14, 2024, 8:30 AM EDT - 11 months ago

BioHarvest Sciences to Participate in Benzinga Virtual Healthcare Summit 2024 on March 20, 2024

BioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unit

Mar 13, 2024, 9:21 AM EDT - 11 months ago

BioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unit

BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on March 12-13, 2024

Mar 7, 2024, 8:30 AM EST - 11 months ago

BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on March 12-13, 2024

BioHarvest Sciences to Host Corporate Update Discussing Launch of CDMO Business Unit on March 13 at 2:30 p.m. Eastern Time

Feb 29, 2024, 11:15 AM EST - 11 months ago

BioHarvest Sciences to Host Corporate Update Discussing Launch of CDMO Business Unit on March 13 at 2:30 p.m. Eastern Time

BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules via Its Newly Launched Botanical Synthesis CDMO Business Unit

Feb 26, 2024, 8:30 AM EST - 11 months ago

BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules via Its Newly Launched Botanical Synthesis CDMO Business Unit

BioHarvest Sciences Issues Clarification to February 15, 2024 News Release Announcing Engagement with IR Firm

Feb 20, 2024, 2:16 PM EST - 11 months ago

BioHarvest Sciences Issues Clarification to February 15, 2024 News Release Announcing Engagement with IR Firm

BioHarvest Sciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

Feb 15, 2024, 8:31 AM EST - 1 year ago

BioHarvest Sciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

BioHarvest Sciences to Present at the 2024 BIO CEO & Investor Conference

Feb 12, 2024, 8:30 AM EST - 1 year ago

BioHarvest Sciences to Present at the 2024 BIO CEO & Investor Conference

BioHarvest Issues 2023 Year End Shareholder Letter and Provides Corporate Update

Jan 8, 2024, 8:00 AM EST - 1 year ago

BioHarvest Issues 2023 Year End Shareholder Letter and Provides Corporate Update

BioHarvest Sciences Inc. Closes Final Tranche of Oversubscribed $13.5M Private Placement

Dec 27, 2023, 8:00 AM EST - 1 year ago

BioHarvest Sciences Inc. Closes Final Tranche of Oversubscribed $13.5M Private Placement

BioHarvest Sciences Inc. (CNVCF) Q3 Shareholder Presentation Call Transcript

Dec 13, 2023, 6:38 PM EST - 1 year ago

BioHarvest Sciences Inc. (CNVCF) Q3 Shareholder Presentation Call Transcript

BioHarvest Sciences Announces Major Product Launch of VINIA-Based Functional Coffees

Dec 13, 2023, 8:00 AM EST - 1 year ago

BioHarvest Sciences Announces Major Product Launch of VINIA-Based Functional Coffees

BioHarvest Sciences to Host Virtual Shareholder Update December 13, 2023, 2:30pm ET

Dec 1, 2023, 2:22 PM EST - 1 year ago

BioHarvest Sciences to Host Virtual Shareholder Update December 13, 2023, 2:30pm ET

BioHarvest Sciences Reports Q3 2023 Revenue Demonstrating Continued Growth Momentum

Nov 29, 2023, 8:00 AM EST - 1 year ago

BioHarvest Sciences Reports Q3 2023 Revenue Demonstrating Continued Growth Momentum

BioHarvest Sciences Inc. Announces $11.78M Raised in First Tranche of $13.5M Private Placement

Oct 30, 2023, 8:00 AM EDT - 1 year ago

BioHarvest Sciences Inc. Announces $11.78M Raised in First Tranche of $13.5M Private Placement

Health Canada Grants BioHarvest Sciences License for VINIA Sales in Canada

Oct 10, 2023, 11:55 AM EDT - 1 year ago

Health Canada Grants BioHarvest Sciences License for VINIA Sales in Canada

BioHarvest Sciences Inc. (CNVCF) Q2 Shareholder Presentation Call Transcript

Sep 7, 2023, 12:52 AM EDT - 1 year ago

BioHarvest Sciences Inc. (CNVCF) Q2 Shareholder Presentation Call Transcript

BioHarvest Announces August 2023 U.S. VINIA Sales Exceeded USD $1Million

Sep 6, 2023, 8:00 AM EDT - 1 year ago

BioHarvest Announces August 2023 U.S. VINIA Sales Exceeded USD $1Million

BioHarvest Sciences Reports Q2 2023 Results Demonstrating Continued Growth Momentum

Aug 30, 2023, 8:00 AM EDT - 1 year ago

BioHarvest Sciences Reports Q2 2023 Results Demonstrating Continued Growth Momentum

BioHarvest Sciences to Host Virtual Shareholder Presentation September 6, 2023

Aug 24, 2023, 8:40 AM EDT - 1 year ago

BioHarvest Sciences to Host Virtual Shareholder Presentation September 6, 2023

BioHarvest Sciences Inc. Announces Closing of Private Placement of Convertible Notes

Jul 18, 2023, 8:00 AM EDT - 1 year ago

BioHarvest Sciences Inc. Announces Closing of Private Placement of Convertible Notes

BioHarvest Chief Medical Officer Shares Personal Journey at Collision Conference

Jun 30, 2023, 8:27 AM EDT - 1 year ago

BioHarvest Chief Medical Officer Shares Personal Journey at Collision Conference

BioHarvest Sciences Chief Medical Officer to Speak at Collision Conference in Toronto

Jun 27, 2023, 8:00 AM EDT - 1 year ago

BioHarvest Sciences Chief Medical Officer to Speak at Collision Conference in Toronto